BIO
Price
$302.92
Change
-$4.86 (-1.58%)
Updated
Nov 19, 01:33 PM (EDT)
Capitalization
8.32B
85 days until earnings call
Intraday BUY SELL Signals
PHG
Price
$26.98
Change
-$0.51 (-1.86%)
Updated
Nov 19, 01:56 PM (EDT)
Capitalization
26.88B
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BIO vs PHG

Header iconBIO vs PHG Comparison
Open Charts BIO vs PHGBanner chart's image
Bio-Rad Laboratories
Price$302.92
Change-$4.86 (-1.58%)
Volume$505
Capitalization8.32B
Koninklijke Philips
Price$26.98
Change-$0.51 (-1.86%)
Volume$3.72K
Capitalization26.88B
BIO vs PHG Comparison Chart in %
BIO
Daily Signal:
Gain/Loss:
PHG
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BIO vs. PHG commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Hold and PHG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (BIO: $307.78 vs. PHG: $27.49)
Brand notoriety: BIO and PHG are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BIO: 70% vs. PHG: 79%
Market capitalization -- BIO: $8.32B vs. PHG: $26.88B
BIO [@Medical/Nursing Services] is valued at $8.32B. PHG’s [@Medical/Nursing Services] market capitalization is $26.88B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $226.05B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 1 FA rating(s) are green whilePHG’s FA Score has 2 green FA rating(s).

  • BIO’s FA Score: 1 green, 4 red.
  • PHG’s FA Score: 2 green, 3 red.
According to our system of comparison, PHG is a better buy in the long-term than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 3 TA indicator(s) are bullish while PHG’s TA Score has 4 bullish TA indicator(s).

  • BIO’s TA Score: 3 bullish, 5 bearish.
  • PHG’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PHG is a better buy in the short-term than BIO.

Price Growth

BIO (@Medical/Nursing Services) experienced а -1.77% price change this week, while PHG (@Medical/Nursing Services) price change was -6.27% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.85%. For the same industry, the average monthly price growth was -7.89%, and the average quarterly price growth was +10.85%.

Reported Earning Dates

BIO is expected to report earnings on Feb 12, 2026.

PHG is expected to report earnings on Feb 10, 2026.

Industries' Descriptions

@Medical/Nursing Services (-4.85% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHG($26.9B) has a higher market cap than BIO($8.32B). PHG has higher P/E ratio than BIO: PHG (147.93) vs BIO (28.81). PHG YTD gains are higher at: 17.248 vs. BIO (-6.310). PHG has higher annual earnings (EBITDA): 2.41B vs. BIO (-631.4M). PHG has more cash in the bank: 1.82B vs. BIO (1.42B). BIO has less debt than PHG: BIO (1.4B) vs PHG (8.43B). PHG has higher revenues than BIO: PHG (17.9B) vs BIO (2.56B).
BIOPHGBIO / PHG
Capitalization8.32B26.9B31%
EBITDA-631.4M2.41B-26%
Gain YTD-6.31017.248-37%
P/E Ratio28.81147.9319%
Revenue2.56B17.9B14%
Total Cash1.42B1.82B78%
Total Debt1.4B8.43B17%
FUNDAMENTALS RATINGS
BIO vs PHG: Fundamental Ratings
BIO
PHG
OUTLOOK RATING
1..100
7074
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9186
PRICE GROWTH RATING
1..100
4950
P/E GROWTH RATING
1..100
289
SEASONALITY SCORE
1..100
503

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PHG's Valuation (14) in the Electronic Production Equipment industry is significantly better than the same rating for BIO (83) in the Medical Specialties industry. This means that PHG’s stock grew significantly faster than BIO’s over the last 12 months.

PHG's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as BIO (100) in the Medical Specialties industry. This means that PHG’s stock grew similarly to BIO’s over the last 12 months.

PHG's SMR Rating (86) in the Electronic Production Equipment industry is in the same range as BIO (91) in the Medical Specialties industry. This means that PHG’s stock grew similarly to BIO’s over the last 12 months.

BIO's Price Growth Rating (49) in the Medical Specialties industry is in the same range as PHG (50) in the Electronic Production Equipment industry. This means that BIO’s stock grew similarly to PHG’s over the last 12 months.

PHG's P/E Growth Rating (9) in the Electronic Production Equipment industry is in the same range as BIO (28) in the Medical Specialties industry. This means that PHG’s stock grew similarly to BIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOPHG
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
52%
Momentum
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 8 days ago
69%
Bullish Trend 8 days ago
61%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 2 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
BIO
Daily Signal:
Gain/Loss:
PHG
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VFINX616.66N/A
N/A
Vanguard 500 Index Investor
ADCCX18.81N/A
N/A
American Century Disciplined Growth C
ANODX24.01N/A
N/A
American Century Small Cap Growth R6
PKAAX14.49N/A
N/A
PIMCO RAE US A
FLIIX12.71N/A
N/A
First Sentier Global Listed Infras I

BIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
+1.22%
A - BIO
68%
Closely correlated
-0.47%
RVTY - BIO
67%
Closely correlated
+2.20%
DHR - BIO
66%
Loosely correlated
+2.30%
MTD - BIO
64%
Loosely correlated
+0.54%
TMO - BIO
63%
Loosely correlated
+1.56%
More

PHG and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHG
1D Price
Change %
PHG100%
-1.75%
RYLPF - PHG
56%
Loosely correlated
N/A
ALC - PHG
49%
Loosely correlated
-1.08%
SYK - PHG
48%
Loosely correlated
-0.17%
MASI - PHG
45%
Loosely correlated
-2.20%
BIO - PHG
43%
Loosely correlated
+1.22%
More